Kinetic Study of Atom Transfer Radical Polymerization of 2-(N,N-Dimethylamino)ethyl Methacrylate

A kinetic model was developed to describe the atom transfer radical polymerization (ATRP) of 2-(N,N-dimethylamino) ethyl methacrylate (DMAEMA). The model was based on a polymerization mechanism,which included the atom transfer equilibrium for primary radical, the propagation of growing polymer radical, and the atom transfer equilibrium for the growing polymer radical. An experiment was carried out to measure the conversion of monomer, the number-average molecular weight of polymer and molecular weight distribution for the ATRP process of DMAEMA. The experimental data were used to correlate the kinetic model and rate constants were obtained. The rate constants of activation and deactivation in the atom transfer equilibrium for primary radical are 1.0×10^4L·mol^-1·s^-1 and 0.04L·mol^-1·s^-1, respectively. The rate constant of the propagation of growing polymer radical is 8.50L·mol^-1·s^-1, and the rate constants of activation and deactivation in the atom transfer equilibrium for growing polymer radical are 0.045L·mol^-1·s^-1 and 1.2×10^5L·mol^-1·s^-1, respectively. The values of the rate constants represent the features of the ATRP process. The kinetic model was used to calculate the ATRP process of DMAEMA. The results show that the calculations agree well with the measurements.

The Synthesis of 7-[1-Aza-2-(dimethylamino)vinyl]-4-methylhydroquinolin-2-ones and their Isomerism in Different Solvents

The reaction of 7-amino-4-methyl-2(1H)-quinolone 1 and its 6-methyl derivative 2 with Vilsmeier reagent (DMF and POCl3) afforded 7-[1-aza-2-(dimethylamino)vinyl]-4-methyl-hydroquinolin-2-one 3 and 7-[1-aza-2-(dimethylamino)vinyl]-4,6-dimethylhydroquinolin- 2-one 4, respec-tively. H-1-NMR analysis in different solvents indicated that isomerism occurred due to hindered rotation around the (CH3)(2)N-C:N o -bond. The rotational energy barrier of 3 was calculated.

Synthesis, Bioactivity, and Crystal Structure Analysis of 2-(3-Oxobenzo[d]isothiazol-2(3H)-yl)ethyl Benzoates

Fifteen novel 2-（3-oxobenzo[d]isothiazol-2（3H）-yl）ethyl benzoates were synthesi- zed by the condensation of 2-（2-hydroxyethyl）benzo[d]isothiazol-3（2H）-one with substituted benzoic acids in dichloromethane. All the compounds were characterized by elemental analysis, IR, ESI-MS and 1H NMR. The crystal structures for 2-（2-hydroxyethyl）benzo[d]isothiazol-3（2H）-one （2） and 2-（3-oxobenzo[d]isothiazol-2（3H）-yl）ethyl 2-methoxybenzoate （30） have been determined by X-ray crystal structure analysis. Compound 2 （C9H9NO2S） crystallizes in the monoclinic system, space group Pn with a = 10.552（3）, b = 7.849（2）, c = 10.765（4） A, β = 103.128（4）°, V= 868.3（5） A3, Mr = 195.24, Dc = 1.493 Mg.m-3, μ = 0.33 mm-1, F（000） = 408, Z = 4, R= 0.0314 and wR= 0.0628. Compound 30 （C17H15NO4S） crystallizes in the triclinic system, space group P1 with a = 8.028（2）, b = 9.300（2）, c = 10.430（3）A, V= 752.1（3）A3, Mr = 329.36, D,= 1.454 Mg.m-3, p = 0.24 mm-1, F（000） = 344, Z = 2, R = 0.0377 and wR = 0.0904. The preliminary biological test indicated that the title compounds show better growth inhibitory activity against the gram-positive bacteria than the gram-negative bacteria.

Synthesis and Crystal Structure of a Novel Ethyl 5-(4-(2-Phenylacetamido)phenyl)-1H-pyrazole-3-carboxylate as an Acrosin Inhibitor

The title compound （ethyl5-（4-（2-phenylacetamido）phenyl）-lH-pyrazole-3-carboxylate, C20H19N3O3） was synthesized by the reaction of Claisen condensation, cyclization, reduction and acylation. The structure was characterized by X-ray diffraction, MS, NMR and IR. It belongs to the monoclinic system, space group C2/c with a = 22.723（9）, b = 9.324（4）, c = 18.890（8） A, β = 114.259（6）°, V = 3649（3） A^3, Dc = 1.272 Mg·m^3, Z = 8, Mr = 349.38, p = 0.087 mm^-1, F（000） = 1472, the final R = 0.0615 and wR = 0.1643. The biological test shows that the title compound has a moderate acrosin inhibition activity.

Long-term and combined effects of N-[2-(nitrooxy)ethyl]-3-pyridinecarboxamide and fumaric acid on methane production,rumen fermentation, and lactation performance in dairy goats

Background:In recent years,nitrooxy compounds have been identified as promising inhibitors of methanogenesis in ruminants.However,when animals receive a nitrooxy compound,a high portion of the spared hydrogen is eructated as gas,which partly offsets the energy savings of CH4mitigation.The objective of the present study was to evaluate the long-term and combined effects of supplementation with N-[2-(nitrooxy)ethyl]-3-pyridinecarboxamide(NPD),a methanogenesis inhibitor,and fumaric acid(FUM),a hydrogen sink,on enteric CH4production,rumen fermentation,bacterial populations,apparent nutrient digestibility,and lactation performance of dairy goats.Results:Twenty-four primiparous dairy goats were used in a randomized complete block design with a 2×2factorial arrangement of treatments:supplementation without or with FUM(32 g/d)or NPD(0.5 g/d).All samples were collected every 3 weeks during a 12-week feeding experiment.Both FUM and NPD supplementation persistently inhibited CH4yield(L/kg DMI,by 18.8%and 18.1%,respectively)without negative influence on DMI or apparent nutrient digestibility.When supplemented in combination,no additive CH4suppression was observed.FUM showed greater responses in increasing the molar proportion of propionate when supplemented with NPD than supplemented alone(by 10.2%vs.4.4%).The rumen microbiota structure in the animals receiving FUM was different from that of the other animals,particularly changed the structure of phylum Firmicutes.Daily milk production and serum total antioxidant capacity were improved by NPD,but the contents of milk fat and protein were decreased,probably due to the bioactivity of absorbed NPD on body metabolism.Conclusions:Supplementing NPD and FUM in combination is a promising way to persistently inhibit CH4emissions with a higher rumen propionate proportion.However,the side effects of this nitrooxy compound on animals and its residues in animal products need further evaluation before it can be used as an animal feed additive.

Synthesis, Crystal Structure and Antitumor Activities of N-(2-(1H-indol-3-yl)ethyl)-2-nitroaniline

The title compound, N-(2-(1H-indol-3-yl)ethyl)-2-nitroaniline(C16H15N3O2, Mr = 281.31), has been synthesized by the multicomponent reaction of milder Ullmann, and its structure was characterized by 1H NMR, 13 C NMR, IR, H RMS(ESI) and single-crystal X-ray diffraction. It crystallizes in monoclinic, space group I2/c with a = 15.0212(10), b = 9.4911(6), c = 20.3075(13) A, β = 100.776(7)o, V = 2844.1(3)A3, Z = 8, Dc = 1.314 g/cm3, F(000) = 1184.0, μ = 0.089 mm-1, the final R = 0.0574 and w R = 0.1688 for 1701 observed reflections(I 】 2σ(I)). X-ray analysis indicates three major N(2)–H(2)···O(2), C(13)–H(13)···O(2), N(2)–H(2)···N(3) hydrogen bonds and π-π stacking interactions in the crystal structure. The preliminary biological test shows that the title compound has a good antitumor activity against A549 in vitro with the IC50 value of 35 μmol/L.

Synthesis and Crystal Structure of Ethyl 3-(4-Chlorophenyl)-3,4-dihydro-6-methyl-4-oxo-2-(pyrrolidin-1-yl)furo[2,3-d]pyrimidine-5-carboxylate

The crystal structure of the title compound ethyl 3-（4-chlorophenyl）-3,4-dihydro-6- methyl-4-oxo-2-（pyrrolidin-1-yl）furo[2,3-d]pyrimidine-5-carboxylate （C20H20ClN3O4, Mr= 401.84） has been prepared and determined by single-crystal X-ray diffraction. The crystal is of monoclinic, space group P21/n with a = 20.6215（9）, b = 8.5311（4）, c = 21.6886（9） A^°, β = 91.607（1）°, V = 3814.0（3）A^°^3, Z = 8, Dc = 1.400 g/cm^3, F（000） = 1680, μ = 0.233 mm^-1, R = 0.0718 and wR = 0.1545 for 6717 observed reflections with I 〉 2σ（I）. X-ray diffraction analysis reveals two crystallographically independent molecules in the asymmetric unit.

A new free recoverable and reusable mono-alkaloid-type ligand and its use in preparation of ethyl(2R,3S)-2,3-dihydroxy-3-phenylpropionate

A new free recoverable and reusable mono-alkaloid-type ligand has been synthesized by a simple method. With highly polar groups, the ligand can be recycled and reused eight times to prepare ethyl （2R,3S）-2,3-dihydroxy-3-phenylpropionate with high yield and ee via asymmetric dihydroxylation （AD） reaction. C 2009 Sheng Yong Zhang. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.

Identification of N-Methyl Bis(2-(Alkyloxy-Alkylphosphoryloxy)Ethyl) Amines by LC-HRMS/MS

N-Methyl bis(2-(alkyloxy-alkylphosphoryloxy)ethyl)amines, which are abbreviated as PNPs, are a series of new skeleton chemicals belonging to schedule 2.B.04 chemicals of Chemical Weapons Convention (CWC). PNPs are important markers of chemical warfare agents because they are structurally relative to both nerve agents and N-mustards. In this study, fragmentation pathways of the most characteristic fragment ions in Q-TOF mass spectrometry were proposed based on the information from accurate mass and secondary fragmentations of product ions scan experiments. Results indicated that the base ion in LC/HRMS was the quasi-molecular ion [M+H]+. In LC-HRMS/MS, it was [M+H-CnH2n+1P(O)(OH)CmH2m+1O]+ fragment ion which was formed by losing an alkyloxy alkylphosphoryloxy group from the quasi-molecular ion. The diagnostic ion m/z84.0814 was identified as [C5H10N]+, which was the group of (CH2=CH)2N+(H)CH3. PNPs have two protonated centers. One is on the N atom, the other is on the O atom (P=O). O-n-propyl PNPs generally exhibited two fragmentation pathways. Firstly, the quasi-molecular ion [M+H]+ lost a propoxy alkylphosphoryloxy group to produce [R1P(OH+)(O-n-C3H7)OCH2CH2N(CH3)CH=CH2]+, which could be fragmented further to produce [C5H10N]+ ion. Secondly, [R1P(OH+)(O-n-C3H7) OCH=CH2]+ ions were produced from [M+H]+ and fragmented further to produce the abundant ions [R1P(OH+)(OH)OCH =CH2]. However, O-isopropyl PNPs characteristically produced weak fragment ions [M+H-C3H6]+, which were presumably formed via loss of CH3CH=CH2 from [M+H]+. Other PNPs showed similar fragmentation pathways as O-n-propyl PNPs. On the summarization of the MS fragmentation pathways of PNPs, LC-HRMS/MS quantitative and qualitative methods were developed and applied to analyze N-Methyl bis(2-(butoxy-methylphosphoryloxy)ethyl]amine in high background organic samples. The analytical results had successfully supported the sample preparation for the 33rd official proficiency test of Organization for Prohibition of Chemical Weapons (OPCW).

Synthesis and Crystal Structure of 4-(4,6-Dimethoxylpyrimidin-2-yl)-3-thiourea Carboxylic Acid Ethyl Ester

4-（4,6-Dimethoxyl-pyrimidin-2-yl）-3-thiourea carboxylic acid ethyl ester was synthesized by the reaction of 2-amino-4,6-dimethoxyl pyrimidine, potassium thiocyanate and methyl chloroformate in ethyl acetate. Single crystals suitable for X-ray measurement were obtained by recrystallization with the solvent of dimethyl formamide at room temperature. The crystal structure was determined by X-ray diffraction analysis. Crystallographic data： C10H14N4O4S, M, = 286.31, monoclinic, space group C2/c with a = 2.5309（3）, b = 0.67682（6）, c = 1.74237（19） nm, β = 114.744（3）°, V= 2.7106（5） nm3, Dc = 1.403 g/cm3, p = 0.225 mm-1, F（000） = 1200, Z= 8, R= 0.0514 and wR= 0.1529.

Synthesis and Crystal Structure of Ethyl 2-(6-(1,3-Dioxo-4,5,6,7-tetrahydro-1H-isoindol-2(3H)-yl)-7-fluoro-3-oxo-2H-benzo[b][1,4]oxazin-4(3H)-yl) Butanoate

The title compound ethyl 2-（6-（1,3-dioxo-4,5,6,7-tetrahydro-lH-isoindol-2（3H）- yl）-7-fluoro-3-oxo-2H-benzo[b][1,4]oxazin-4（3H）-yl） butanoate 3 was synthesized by the reaction of ethyl 2-（6-amino-7-fluoro-3-oxo-2H-benzo[b][1,4]oxazin-4（3H）-yl） butanoate with 4,5,6,7- tetraydrophthalic anhydride, and its structure was determined by X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P2 1/n with a = 9.3469（2）, b = 16.7715（5）, c = 13.7153（4） A, β= 104.9680（10）°, μ = 0.107 mm^-1, Mr = 430.42, V= 2077.08（10） ,A3, Z= 4, Dc = 1.376 g/cm3, F（000） = 904, T= 296（2） K, R = 0.0508 and wR = 0.1478.

Synthesis of Temperature- and pH-Sensitive Graft Copolymer Containing 2-(Diethylamino)ethyl Methacrylate and N-Vinylcaprolactam onto Silicone Rubber

Silicone rubber films were modified by the consecutive grafting of 2-(diethylamino)ethyl methacrylate (DEAEMA) and N-vinylcaprolactam (NVCL) using direct method on two steps with gamma-rays. The effect of absorbed dose and monomer concentration on grafting degree was determined. The grafted samples were verified by FTIR-ATR spectroscopy and swelling;thermal properties were analyzed by DSC and TGA. The stimuli-responsive behavior was studied by swelling and/or DSC. Thermo- and pH-sensitive films of (PP-g-DEAEMA)-g-NVCL presented a pH critical at 3.2 and LCST around 63.5℃.

真丝绸表面光接枝2-(双甲基胺)乙基甲基丙烯酸酯改性研究

A new method has been established to graft vinyl monomers onto silk fabrics by ultraviolet rays without any initiator or photosensitizer, in an attempt to improve undesirable properties of the materials with increased wrinkle recovery, better dyeing ability and color-fastness, and higher resistance to photo-yellowing, etc. In this work, ef- fectiveness of different types of UV devices and experimental conditions of the photo-induced graft-copolymeri- zation were investigated to control the influential factors on the grafting yield and properties of the graft-copolymer. Surface characteristics and structure changes, thermal properties and wrinkle resistance of grafted silk fabrics were studied. The grafted silk fabrics showed improved properties in crease resistance, dyeing ability and color-fastness, and heat stability as well. In detail, graft-copolymerization of 2-(Dimethylamino)ethyl methacrylate onto silk fabrics can make silk fabrics undergo from slight to drastic changes in their dyeing behavior, i.e., rate of dyeing and uptake of acid dyes. Different reaction systems of the same monomer can lead to reverse dyeing properties, indicating not only the function but also the structure affects the properties of grafted silk fab- rics, especially the color-fastness. The UV light graft copolymerization method is of significance in silk industrial applications in terms of the facility cost, operation convenience and grafting efficiency, in comparison to Co 60 γ-ray and electron beam irradiation facilities.

大豆分离蛋白接枝氨基封端聚2-丙烯酰胺基-2-甲基丙磺酸的合成及溶液性质研究

用巯基乙胺为链转移剂,过硫酸铵为引发剂合成了氨基封端的聚2-丙烯酰胺基-2-甲基丙磺酸(H2N-PAMPS).再用1-(3-二甲氨基丙基)-3-乙基碳二亚胺盐酸盐(EDC)和N-羟基琥珀酰亚胺(NHS)在室温下催化H2N-PAMPS的端氨基与大豆分离蛋白(SPI)的羧基反应形成酰胺键,得到接枝物SPI-g-NH-PAMPS.用1H-NMR、傅利叶红外光谱、13C-NMR对H2N-PAMPS和接枝物SPI-g-NH-PAMPS进行结构表征.用zeta电位仪、紫外可见光光谱,荧光光谱,动态激光光散射对SPI及其接枝物SPI-g-NH-PAMPS的水溶液性质进行了研究.结果表明,与SPI相比,SPI-g-NH-PAMPS的溶解性、表面疏水性、乳化性等有所改善,接枝物SPI-g-NH-PAMPS聚集体粒径增大,形成独特的核壳结构.

4-(2-N,N-二甲氨基-乙基)磺酰基-苯肼的合成

芳香肼4-(2-N,N-二甲氨基-乙基)磺酰基-苯肼是阳离子荧光增白剂CH制备的重要中间体,采用对位酯为原料,经过水解,加胺得到芳香胺,再经重氮化、还原的合成路线得到。还原过程中采用氯化亚锡作为还原剂提高芳香肼的收率(85%)。用熔点、红外、核磁、元素分析对产品结构进行表证。

氧阴离子引发甲基丙烯酸-2-(N,N-二甲氨基)乙酯聚合制备Y型大分子单体

A novel well-defined water-soluble macromonomer based on 2-(dimethylamino) ethyl methacry-late(DMAEMA) was synthesized by using functional initiators such as potassium alcoholate of trimethylol-propane allyl ether via oxyanion-initiated polymerization. GPC and 1H NMR studies confirmed that themacromonomers had narrow molecular weight distribution and each Poly(DMAEMA) chain contained apolymerizable allyl group. The macromonomers were highly surface active in aqueous media. They havepotential applications in preparation of surface-clean and functional latexes both as effective stabilizers andas co-monomers.

1-[2-(N,N-二甲基氨基)乙基]-5-巯基-1H-四氮唑的制备

介绍了一种1-[2-(N,N-二甲基氨基)乙基]-5-巯基-1H-四氮唑(DMMT)的合成方法。2-(N,N-二甲基氨基)乙胺与二硫化碳反应,制得取代的2-(N,N-二甲基氨基)乙胺基二硫代羧酸;2-(N,N-二甲基氨基)乙胺基二硫代羧酸与氯甲酸乙酯反应,得到2-(N,N-二甲基氨基)乙胺基二硫代羧酸与乙氧基甲酸的二硫代酸酐;二硫代酸酐再经三乙胺碱解,制得2-(N,N-二甲基氨基)乙基异硫氰酸酯;2-(N,N-二甲基氨基)乙基异硫氰酸酯与叠氮化钠反应,制得目标产物1-[2-(N,N-二甲基氨基)乙基]-5-巯基-1H-四氮唑(DMMT)。产物以N,N-二甲基氨基乙胺计,收率为48.0%。采用该法,能够方便地制得1-[2-(N,N-二甲基氨基)乙基]-5-巯基-1H-四氮唑,产物收率高,反应条件温和,操作过程简便,三废少,环境污染小。

抗癌药1,4-二[2-(二甲胺基)乙胺基]-5,8-二羟基蒽醌的合成研究

以2，3-二氢-1，4，5，8-四羟基蒽醌和N，N-二甲基乙二胺为原料，合成了抗癌药物1，4-二[2-（二甲胺基）乙胺基]-5，8-二羟基蒽醌（下称：AQ4），考察了温度、溶剂、催化剂、氧化方式等对其产品收率的影响．确定的较佳工艺方法为：以2，3-二氢-1，4，5，8-四羟基蒽醌和N，N-二甲基乙二胺为起始原料进行缩合反应，用N，N-二甲基乙二胺兼做溶剂，首先制得1，4-二[2-（二甲胺基）乙胺基]-5，8-二羟基蒽醌隐色体（AQ4隐色体），进而用硝基苯进行氧化反应制得AQ4，产品总收率达到67．5％，产品结构利用红外（IR）、核磁（。HNMR）进行了表征．较佳的缩合反应条件为：反应温度50～55℃、反应时间2h；较佳的氧化反应条件为：反应温度140～145℃、回流反应时间15min．

用4,9-二[N-(2-二甲氨基)乙基]-9-吖啶胺-4-甲酰胺测定微量蛋白质

应用水溶性4,9-二[N-(2-二甲氨基)乙基]-9-吖啶胺-4-甲酰胺(DNAF)探针,并结合十二烷基硫酸钠(SDS),研究DNAF-SDS体系用于牛血清白蛋白(BSA)的定量测定方案。线性范围为5.0×10-9～8.3×10-7 mol/L,检出限为1.0×10-10 mol/L。4,9-二[N-(2-二甲氨基)乙基]-9-吖啶胺-4-甲酰胺作为一种新型的荧光染料探针在微量蛋白质定量测定方面具有良好应用潜力。

4,9-二[N-(2-二甲氨基)乙基]-9-吖啶胺-4-甲酰胺与蛋白质相互作用

应用水溶性4,9-二[N-(2-二甲氨基)乙基]-9-吖啶胺-4-甲酰胺(DNAF)探针,研究了DNAF与牛血清白蛋白(BSA)的相互结合作用机理。计算出相应的热力学参数ΔH、ΔG以及ΔS;通过荧光猝灭方法研究结合作用,测定出结合位点数n和表观结合常数KA;根据荧光共振能量转移理论求得供体BSA和受体DNAF的距离r;研究了DNAF对蛋白质内源荧光猝灭的猝灭机制和主要作用力类型。